Similar effects have been reported by Vestergaard et al. who detected elevated serum levels of TFF1 and -3 in patients suffering from inflammatory bowel disease [50]; and a study of Viby et al. found elevated serum levels of TFF1, -2 and -3 in patients with COPD [51]. This evidence concerns the gene TFF1 and chronic obstructive pulmonary disease.